Literature DB >> 15255131

Osteal complications as first manifestation in a patient with primary Sjögren's Syndrome and with associated distal tubular acidosis (type 1) and chronic renal insufficiency.

C Díaz Rodríguez1, C González Rivero, J C Trinidad San José, D Del Río Romero, A Moreno Fernández, E Granja Romero.   

Abstract

Renal affection is among the complications associated with the Sjögren's Syndrome. Tubulo-interstitial nephritis constitutes the most frequent renal lesion and distal tubular acidosis (Type 1) is the most important clinical manifestation of this tubular dysfunction, although the occurrence of chronic renal insufficiency is not an uncommon finding in the presence of distal renal tubular acidosis. Osteomalacia is a clinical consequence of tubular acidosis caused by buffering of H+ in the bone. We present the case of a woman with osteal complication a year before being diagnosed with primary Sjögren's Syndrome and with distal tubular acidosis and renal insufficiency associated at diagnosis.

Entities:  

Mesh:

Year:  2004        PMID: 15255131     DOI: 10.1111/j.1526-0968.2003.00122.x

Source DB:  PubMed          Journal:  Ther Apher Dial        ISSN: 1744-9979            Impact factor:   1.762


  3 in total

1.  Osteomalacia secondary to renal tubular acidosis due to Sjögren's syndrome: a case report and review of the literature.

Authors:  Hiroshi Nagae; Yuko Noguchi; Shinako Ogata; Chinami Ogata; Rei Matsui; Yukiko Shimomura; Ritsuko Katafuchi
Journal:  CEN Case Rep       Date:  2012-08-15

Review 2.  Tubulointerstitial nephritis-induced hypophosphatemic osteomalacia in Sjögren's syndrome: a case report and review of the literature.

Authors:  Yan Geng; Youlu Zhao; Zhuoli Zhang
Journal:  Clin Rheumatol       Date:  2017-07-20       Impact factor: 2.980

3.  Sjögren's, Renal Tubular Acidosis And Osteomalacia - An Asian Indian Series.

Authors:  Pulukool Sandhya; Debashish Danda; Simon Rajaratnam; Nihal Thomas
Journal:  Open Rheumatol J       Date:  2014-12-19
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.